Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prendergast

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
The Lancet. Oncology|March 22, 2002
Mode of action of farnesyltransferase inhibitorsG C Prendergast
Nature Reviews. Cancer|March 22, 2002
Actin' up: RhoB in cancer and apoptosisG C Prendergast
Nature Biotechnology|October 3, 2001
Knockout drug screensG C Prendergast
Cancer Biology & Therapy|September 24, 2005
Chasing cancer: from genes to drugsGeorge C Prendergast
Cancer Research|March 17, 2011
Perspectives on emerging trends in cancer researchGeorge C Prendergast
Oncoimmunology|November 20, 2012
Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the futureGeorge C Prendergast
Oncogene|June 23, 1999
Myc and Myb: are the veils beginning to lift?G C Prendergast
Nature|October 14, 2011
Cancer: Why tumours eat tryptophanGeorge C Prendergast
Histology and Histopathology|February 24, 2001
Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiologyG C Prendergast
Current Opinion in Cell Biology|March 14, 2000
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospectsG C Prendergast
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
The Lancet. Oncology|March 22, 2002
Mode of action of farnesyltransferase inhibitorsG C Prendergast
Nature Reviews. Cancer|March 22, 2002
Actin' up: RhoB in cancer and apoptosisG C Prendergast
Nature Biotechnology|October 3, 2001
Knockout drug screensG C Prendergast
Cancer Biology & Therapy|September 24, 2005
Chasing cancer: from genes to drugsGeorge C Prendergast
Cancer Research|March 17, 2011
Perspectives on emerging trends in cancer researchGeorge C Prendergast
Oncoimmunology|November 20, 2012
Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the futureGeorge C Prendergast
Oncogene|June 23, 1999
Myc and Myb: are the veils beginning to lift?G C Prendergast
Nature|October 14, 2011
Cancer: Why tumours eat tryptophanGeorge C Prendergast
Histology and Histopathology|February 24, 2001
Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiologyG C Prendergast
Current Opinion in Cell Biology|March 14, 2000
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospectsG C Prendergast
Pageof 25